Cyprotex (CRX)

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

 43.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 130.00
  • 52 Week Low: 43.50
  • Currency: UK Pounds
  • Shares Issued: 22.44m
  • Volume: 0
  • Market Cap: £9.76m
  • RiskGrade: 144
  • Beta: 0.71

Detailed Cyprotex Share Price Data

Share Price 43.50p Close 43.50p
Change Today 0.000p Volume 0
Percent Change n/a % Day High / Low 43.50p / 43.50p
Update Time 11:44:01 Year High / Low 130.00p / 43.50p
Bid 42.00p Last Trade Price n/a
Offer 45.00p Last Trade Amount n/a
Open 43.50p Last Trade Time n/a

Detailed Cyprotex Share Price Changes

Period Price Change Percent Change
1 week 44.50p -1.00p -2.25%
1 month 51.00p -7.50p -14.71%
3 months 65.00p -21.50p -33.08%
6 months 56.25p -12.75p -22.67%
1 year 58.75p -15.25p -25.96%

Additional Share Price Data

Ex-Marker Code Ex-Other NMS 3,000
Ex-Marker Start 03-Sep-13 VWAP 0.000p
Ex-Marker End 30-Sep-13 Beta 0.71

Related Market Prices

Index / Sector Value Change Percent Change
FTSE AIM All-Share 713.68 -1.51 -0.21%
Pharmaceuticals & Biotechnology 12,470.12 +34.38 +0.28%

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cyprotex Market Data

Currency UK Pounds
Share Price 43.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 130.00
52 Week Low 43.50
Volume 0
Shares Issued 22.44m
Market Cap £9.76m
Beta 0.71
RiskGrade 144

Cyprotex Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
11.39% below the market average11.39% below the market average11.39% below the market average11.39% below the market average11.39% below the market average
48.84% above the sector average48.84% above the sector average48.84% above the sector average48.84% above the sector average48.84% above the sector average
Price Trend
53.37% below the market average53.37% below the market average53.37% below the market average53.37% below the market average53.37% below the market average
48.15% below the sector average48.15% below the sector average48.15% below the sector average48.15% below the sector average48.15% below the sector average
Income Not Available
Growth
21.41% below the market average21.41% below the market average21.41% below the market average21.41% below the market average21.41% below the market average
7.69% below the sector average7.69% below the sector average7.69% below the sector average7.69% below the sector average7.69% below the sector average

Cyprotex Dividends

No dividends found

Trades for --2014

Time Volume / Share Price
0 @ 0.000p

Cyprotex Key Personnel

CEO Anthony Baxter
CFO John Dootson

Top of Page